Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas

Published 2008 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas
Authors
Keywords
-
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 89, Issue 2, Pages 179-185
Publisher
Springer Nature
Online
2008-04-22
DOI
10.1007/s11060-008-9600-y

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.